Tectonic Therapeutic | AVRO - Market Capitalization


Tectonic Therapeutic reported $332.2M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alnylam Pharmaceuticals USD 59.77B 17.25B Sep/2025
Celltrion KRW 40.04T 3.19T Sep/2025
Cspc Pharmaceutical CNY 107.03B 26.09B Sep/2025
Dianthus Therapeutics USD 1.57B 1000K Feb/2026
Divis Laboratories Ltd INR 1.51T 297.32B Sep/2025
Gilead Sciences USD 137.73B 184M Sep/2025
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
Kangmei Pharma CNY 27.93B 1.73B Sep/2025
Knight Therapeutics CAD 580.82M 31.21M Jun/2025
Laboratorios Farma EUR 3.68B 430.05M Jan/2026
MacroGenics USD 114M 8M Feb/2026
Malin Corporation EUR 150.45M 12.13M Jan/2026
Medical Developments International AUD 61.96M 16.34M Jun/2025
Neuren Pharmaceuticals AUD 1.75B 152.5M Jun/2025
Organigram Holdings CAD 191.77M 187.03M Feb/2026
Pfizer USD 147.57B 12.48B Feb/2026
Pharma Mar EUR 1.63B 241.7M Sep/2025
Qiagen NV USD 9.69B 719.54M Sep/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Sarepta Therapeutics USD 2.02B 336M Sep/2025
Sartorius EUR 8.36B 8.04B Feb/2026
Sino Biopharmaceutical CNY 90.06B 33.55B Jun/2025
Takeda JPY 7.64T 774.9B Dec/2025
Zz Pientze Pharmaceu CNY 118.73B 1.94B Sep/2025